#846 – The Industry Wire

  1. Is Epic’s EHR dominance choking IT innovation?
  2. HHS moves to ease peptide access, sparking concerns.
  3. Eli Lilly drug could double weight-loss rate versus Ozempic. 
  4. ChatGPT maker sued for telling woman to go off epilepsy meds. 
  5. Bon Secours Mercy buys Surgery Partners stake.
  6. ADA apologizes to researchers kicked out of diabetes meeting.
  7. How Medicare cuts to remote monitoring could affect patients. 
  8. Artiva Bio halts trial of cell therapy for autoimmune diseases. 
  9. Congress looks to fix dispute resolution in No Surprises Act.
  10. Pediatric ICUs are closing nationwide. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like